Beneficial effects of ginsenoside-Rg1 on ischemia-induced angiogenesis in diabetic mice

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 12, 2012, Pages 999-1005

  Yang, Naiquan ^a,b   Chen, Pengsheng ^a   Tao, Zhiwen ^a   Zhou, Ningtian ^a   Gong, Xiaoxuan ^a   Xu, Zhihui ^a   Zhang, Min ^a   Zhang, Dingguo ^a   Chen, Bo ^a   Tao, Zhengxian ^a   Yang, Zhijian ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

angiogenesis; ginsenoside Rg1; hindlimb ischemia

Indexed keywords

CD31 ANTIGEN; CENTRAL NERVOUS SYSTEM AGENTS; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GINSENOSIDE; GINSENOSIDE RG 1; HERBACEOUS AGENT; VASCULOTROPIN A;

ANIMAL; ARTICLE; BLOOD; BLOOD FLOW; C57BL MOUSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE BLOOD LEVEL; HINDLIMB; ISCHEMIA; LASER DOPPLER FLOWMETRY; MALE; METABOLISM; METHODOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); SKELETAL MUSCLE; VASCULARIZATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD31; BLOOD GLUCOSE; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DRUGS, CHINESE HERBAL; FLUORESCENT ANTIBODY TECHNIQUE; GINSENOSIDES; HINDLIMB; ISCHEMIA; LASER-DOPPLER FLOWMETRY; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; REGIONAL BLOOD FLOW; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS; PANAX GINSENG;

EID: 84870152978     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms092     Document Type: Article

References (37)

1. Aboyans V, Lacroix P, Tran MH, Salamagne C, Galinat S, Archambeaud F and Criqui MH, et al. The prognosis of diabetic patients with high ankle-brachial index depends on the coexistence of occlusive peripheral artery disease. J Vasc Surg 2011, 53: 984-991.
2. Mukherjee D. Peripheral and cerebrovascular atherosclerotic disease in diabetes mellitus. Best Pract Res Clin Endocrinol Metab 2009, 23: 335-345.
3. Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, Barateau V, Lecomte-Raclet L, Clergue M and Duriez M, et al. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol 2004, 164: 457-466.
4. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B and Peters K, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999, 154: 355-363.
5. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 2001, 49: 554-560.
6. Dong L, Kang L, Ding L, Chen Q, Bai J, Gu R and Li L, et al. Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice. Microvasc Res 2011, 82: 227-236.
7. Wu CH, Wang CC and Kennedy J. Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clin Ther 2011, 33: 1749-1758.
8. Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004, 9: 259-274.
9. Radad K, Gille G, Moldzio R, Saito H and Rausch WD. Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res 2004, 1021: 41-53.
10. Huang YC, Lin CY, Huang SF, Lin HC, Chang WL and Chang TC. Effect and mechanism of ginsenosides CK and Rg1 on stimulation of glucose uptake in 3T3-L1 adipocytes. J Agric Food Chem 2010, 58: 6039-6047.
11. Park S, Ahn IS, Kwon DY, Ko BS and Jun WK. Ginsenosides Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance beta-cell insulin secretion and viability in Min6 cells via PKA-dependent pathways. Biosci Biotechnol Biochem 2008, 72: 2815-2823.
12. Kim SJ, Yuan HD and Chung SH. Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells. Biol Pharm Bull 2010, 33: 325-328.
13. Yue PYK, Wong DYL, Ha WY, Fung MC, Mak NK, Yeung HWand Leung HW, et al. Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg1 in vivo and in vitro. Angiogenesis 2005, 8: 205-216.
14. Liang HC, Chen CT, Chang Y, Huang YC, Chen SC and Sung HW. Loading of a novel angiogenic agent, ginsenoside Rg1 in an acellular biological tissue for tissue regeneration. Tissue Eng 2005, 11: 835-846.
15. Leung KW, Cheng YK, Mak NK, Chan KK, Fan TP and Wong RN. Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells. FEBS Lett 2006, 580: 3211-3216.
16. Leung KW, Ng HM, Tang MK, Wong CC, Wong RN and Wong AS. Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1a to promote angiogenesis. Angiogenesis 2011, 14: 515-522.
17. Qin X, Zhang Z, Xu H and Wu Y. Notch signaling protects retina from nuclear factor-kB-and poly-ADP-ribose-polymerase-mediated apoptosis under high-glucose stimulation. Acta Biochim Biophys Sin 2011, 43: 703-711.
18. Senthilkumar A, Smith RD, Khitha J, Arora N, Veerareddy S, Langston W and Chidlow JH, Jr, et al. Sildenafil promotes ischemia-induced angiogenesis through a PKG-dependent pathway. Arterioscler Thromb and Vasc Biol 2007, 27: 1947-1954.
19. Emanueli C, Monopoli A, Kraenkel N, Meloni M, Gadau S, Campesi I and Ongini E, et al. Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb ischaemia in type-1 diabetic mice. Br J Pharmacol 2007, 150: 873-882.
20. Pattillo CB, Bir SC, Branch BG, Greber E, Shen X, Pardue S and Patel RP, et al. Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress. Free Radic Biol Med 2011, 50: 262-269.
21. Zhao Y, Tao Z, Xu Z, Tao Z, Chen B, Wang L and Li C, et al. Toxic effects of a high dose of non-ionic iodinated contrast media on renal glomerular and aortic endothelial cells in aged rats in vivo. Toxicol Lett 2011, 202: 253-260.
22. Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA and Yoon SS. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Cancer Res 2005, 65: 5881-5889.
23. Hu Z, Zhang F, Yang Z, Yang N, Zhang D, Zhang J and Cao K. Combination of simvastatin administration and EPC transplantation enhances angiogenesis and protects against apoptosis for hindlimb ischemia. J Biomed Sci 2008, 15: 509-517.
24. Liu J, Guo W, Xu B, Ran F, Chu M, Fu H and Cui J. Angiogenesis inhibition and cell cycle arrest induced by treatment with Pseudolarix acid B alone or combined with 5-fluorouracil. Acta Biochim Biophys Sin 2012, 44: 490-502.
25. Sotaniemi EA, Haapakoski E and Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995, 18: 1373-1375.
26. Vuksan V, Sievenpiper JL, Koo VY, Francis T, Beljan-Zdravkovic U, Xu Z and Vidgen E. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 2000, 160: 1009-1013.
27. Yang CY, Wang J, Zhao Y, Shen L, Jiang X, Xie ZG and Liang N, et al. Anti-diabetic effects of Panax notoginseng saponins and its major antihyperglycemic components. J Ethnopharmacol 2010, 130: 231-236.
28. Song X, Liu S, Qu X, Hu Y, Zhang X, Wang T and Wei F. BMP2 and VEGF promote angiogenesis but retard terminal differentiation of osteoblasts in bone regeneration by up-regulating Id1. Acta Biochim Biophys Sin 2011, 43: 796-804.
29. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladstone SR and Friedman M, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995, 1: 1085-1089.
30. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T and Rosenfield K, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996, 348: 370-374.
31. Tao Z, Chen B, Tan X, Zhao Y, Wang L, Zhu T and Cao K, et al. Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci USA 2011, 108: 2064-2069.
32. Yin H, Liu Z, Li F, Ni M, Wang B, Qiao Y and Xu X, et al. Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction. J Mol Med 2011, 89: 363-375.
33. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG and Nedeau A, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007, 117: 1249-1259.
34. Park B, Hoffman A, Yang Y, Yan J, Tie G, Bagshahi H and Nowicki PT, et al. Endothelial nitric oxide synthase affects both early and late collateral arterial adaptation and blood flow recovery after induction of hind limb ischemia in mice. J Vasc Surg 2010, 51: 165-173.
35. Lim H, Fallavollita JA, Hard R, Kerr CW and Canty JM, Jr. Profound apoptosis-mediated regional myocyte loss and compensatory hypertrophy in pigs with hibernating myocardium. Circulation 1999, 100: 2380-2386.
36. Emanueli C, Graiani G, Salis MB, Gadau S, Desortes E and Madeddu P. Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice. Diabetes 2004, 53: 1096-1103.
37. Cheung LW, Leung KW, Wong CK, Wong RN and Wong AS. Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1. Cardiovasc Res 2010, 89: 419-425.